GIRGENTI STEVEN 4

4 · bioAffinity Technologies, Inc. · Filed Jul 2, 2024

Insider Transaction Report

Form 4
Period: 2024-07-01
GIRGENTI STEVEN
DirectorExecutive Chairman
Transactions
  • Award

    Common Stock

    2024-07-01+33,7841,065,248 total
Holdings
  • Common Stock

    (indirect: By Trust)
    8,955
Footnotes (2)
  • [F1]Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024.
  • [F2]These shares are owned directly by the Cranye Girgenti Testamentary Trust (the "Trust"). The reporting person is a co-trustee of the Trust. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Documents

1 file
  • 4
    ownership.xmlPrimary